Long-term follow-up for multidrug-resistant tuberculosis

Emerg Infect Dis. 2006 Apr;12(4):687-8. doi: 10.3201/eid1204.041256.

Abstract

Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median of 67 months. Among 86 patients considered cured after completion of treatment, 97% remain healthy; 1 patient relapsed. Employment increased from 34% before treatment to 71%. We observed favorable long-term outcomes among MDR-TB patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents
  • Drug Resistance, Multiple, Bacterial*
  • Humans
  • Mycobacterium tuberculosis / drug effects*
  • Peru / epidemiology
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome
  • Tuberculosis / drug therapy*
  • Tuberculosis / epidemiology
  • Tuberculosis / microbiology*

Substances

  • Antitubercular Agents